HRGN

PINK Harvard Apparatus Regenerative Technology Inc
Oct 23, 2026 · 3:54 AM ET EOD Market Closed

$1.97 ↓ -0.09 (-4.37%) Trading Down from the previous close of $2.06, and at the day’s high of $1.97

YTD change
+25.32%
vs 20-day SMA
-9.13%
vs 200-day SMA
N/A

Price ranges

Previous day
$1.97 $1.97
open $1.97 close $1.97
+$0.00 (+0.00%)
Today
$1.97 $1.97
$1.97
Past week
$2.06 $2.30
from $2.25 now $1.97
-$0.28 (-12.44%)
Past month
$1.81 $2.33
from $2.25 now $1.97
-$0.28 (-12.44%)
This year
$0.96 $2.46
from $1.57 now $1.97
+$0.40 (+25.32%)

Price & Performance

+0.43 (+27.92%) / 6M

$0.8920$1.41$1.94$2.46Apr 23Aug 13Oct 22

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A
  • The stock is 20.0% away from all-time highs of $2.46
  • HRGN is up 25% since the beginning of the year
  • HRGN is up 25% over the past 12 months
  • HRGN is down 12% over the past 1 month
  • 0% of all HRGN investors are betting against HRGN

HRGN reads n/a: the 12-month move is +8.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.0964
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio -6.95
Enterprise value $36.6M
Beta 0.11

Balance sheet & scale

IncomeN/A
Revenue$982.0K
Cash$351.0K
Debt$691.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Market cap $40.0M

Harvard Apparatus Regenerative Technology, Inc. is a clinical-stage biotechnology company, which engages in the development of organ implants to treat congenital defects, cancers, and life-threatening conditions of the esophagus, bronchus and trachea. The company was founded by David Green on May 3, 2012 and is headquartered in Holliston, MA.

Competitor comparison

No peer group available for this symbol.

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.